Review Finds Cancer Patients Report Discrimination in Family, Work, Insurance, Health Care
Cancer patients report abandonment by partners, job loss, insurance denials and blame from doctors, according to a scoping review of 116 studies published in
Psycho-Oncology in 2026 by researchers at Flinders University in Adelaide, Australia.
The findings describe discrimination across four domains: family and social relationships, employment, insurance and health care. According to the review, the accounts include spouses who refused permission for surgery, employers who rejected applicants after learning of a cancer history, insurers who denied coverage after genetic testing and clinicians who assumed lung cancer patients had smoked.
Because most of the included studies relied on personal accounts rather than population-based sampling, the review could not establish how common these experiences are among cancer patients overall, according to the authors. The paper's stated limitations also note that the review did not formally appraise the quality of individual studies or test whether recommended remedies work.
Review Scope and Methodology
Researchers searched major research databases for English-language studies published from 2004 through December 2025 and identified more than 3,100 records, according to the review. Two reviewers independently screened the records and included 116 studies in the final analysis. Of those, 83 were qualitative studies that collected people's own descriptions, while the remainder used mixed methods or summarized earlier reviews.
The authors reported that family and social treatment came up most often in studies from Asia and Africa, while work and insurance problems were reported more in North America. The review cautioned that such geographic gaps may reflect differences in research priorities rather than true regional differences in the prevalence of discrimination.
The scoping review design means the authors mapped the available evidence rather than pooling results into a single statistical estimate. That approach allows a broad view of what patients have reported across settings, but it limits the conclusions that can be drawn about frequency or cause and effect, according to the paper's stated limitations.
Family and Social Accounts
The review stated that much of the reported treatment at home and in communities was linked to misinformation, especially the belief that cancer is contagious. That belief led to avoidance, exclusion and in some cases bullying of people with visible treatment effects.
According to the review, some accounts described cancer as divine punishment or karma, and gender expectations added pressure. Women reported judgments about femininity, fertility and marriage prospects, while men with prostate or breast cancer described threats to masculinity and workplace standing.
Spouses figured in some accounts. The review stated that a spouse refused permission for a mastectomy, partners threatened to leave or remarry if treatment proceeded, and a separated spouse used a partner's illness in a custody dispute. The review also cited a survey in which 71.8% of 1,011 Korean adults with no cancer history believed cancer survivors would never be able to contribute to society.
These accounts sit alongside a broader body of research on the social and psychological toll of a cancer diagnosis. Studies of genetic testing for hereditary cancer have documented the strong emotions many men express about the impact of the disease on their female relatives, even when those men do not share the same preoccupation with their own cancer risk [1].
Work, Insurance and Health Care Accounts
Studies described employers and colleagues holding stereotypes that cancer survivors would need too much time off or were likely to relapse. According to the review, applicants were rejected after disclosing a cancer history, and workers were demoted or pressured to resign. The review stated that some participants were denied insurance coverage after genetic testing, while others declined testing to protect their coverage. In one study, long-term survivors could not get employer life insurance despite being cancer-free for more than 10 years.
The financial strain described in the review aligns with a larger literature on the economic burden of cancer. A separate analysis concluded that a high percentage of cancer patients and their families and caregivers experience out-of-pocket expenditure, loss of income and lost productivity [2].
Judgment from health care providers appeared most often in studies of lung cancer patients, who reported being assumed to have smoked whether or not it was true and receiving less empathy as a result, according to the review. In Australia, bereaved caregivers said the welfare system repeatedly questioned or rejected medical certificates and demanded proof of job-seeking while they grieved, the review stated.
Consequences, Limitations and Recommendations
Across settings, patients and caregivers reported anxiety, depression, guilt and lower self-worth, according to the review. Some hid their diagnosis from family, employers or schools, and some lung cancer patients withheld smoking history from doctors or pulled away from health care to avoid judgment. The review stated that job loss, medical bills and insurance gaps left some people in debt or with unstable housing, and that financial or employment insecurity may lead people to stop or opt out of treatment.
The authors called for public education, workplace and insurance reforms, legal protections and better training for health care workers. The review noted that it did not test whether those measures work. The paper's stated limitations also include its restriction to peer-reviewed English-language studies and the absence of a formal appraisal of individual study quality, which together mean the review could not measure how common cancer-related discrimination is or establish cause and effect.
References
- Genetic testing for cancer psychological approaches for helping patients and families. Patenaude Andrea Farka
- The economic impact of cancer diagnosis to individuals and their .... https://pmc.ncbi.nlm.nih.gov/articles/PMC9213304/
Explainer Infographic